613 related articles for article (PubMed ID: 11825097)
1. Population pharmacokinetic model to predict steady-state exposure to once-daily cyclosporin microemulsion in renal transplant recipients.
Schädeli F; Marti HP; Frey FJ; Uehlinger DE
Clin Pharmacokinet; 2002; 41(1):59-69. PubMed ID: 11825097
[TBL] [Abstract][Full Text] [Related]
2. Effect of gastrointestinal inflammation and age on the pharmacokinetics of oral microemulsion cyclosporin A in the first month after bone marrow transplantation.
Schultz KR; Nevill TJ; Balshaw RF; Toze CL; Corr T; Currie CJ; Strong DK; Keown PA
Bone Marrow Transplant; 2000 Sep; 26(5):545-51. PubMed ID: 11019845
[TBL] [Abstract][Full Text] [Related]
3. Absorption profiling of cyclosporine microemulsion (neoral) during the first 2 weeks after renal transplantation.
Canadian Neoral Renal Transplantation Study Group
Transplantation; 2001 Sep; 72(6):1024-32. PubMed ID: 11579295
[TBL] [Abstract][Full Text] [Related]
4. Dose adjustment strategy for oral microemulsion formulation of cyclosporine: population pharmacokinetics-based analysis in kidney transplant patients.
Tokui K; Kimata T; Uchida K; Yuasa H; Hayashi Y; Itatsu T; Nabeshima T
Ther Drug Monit; 2004 Jun; 26(3):287-94. PubMed ID: 15167630
[TBL] [Abstract][Full Text] [Related]
5. A comparison of measured trough levels and abbreviated AUC estimation by limited sampling strategies for monitoring mycophenolic acid exposure in stable heart transplant patients receiving cyclosporin A-containing and cyclosporin A-free immunosuppressive regimens.
Dösch AO; Ehlermann P; Koch A; Remppis A; Katus HA; Dengler TJ
Clin Ther; 2006 Jun; 28(6):893-905. PubMed ID: 16860172
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of two oral cyclosporin a formulations in clinically stable heart-transplant patients.
Baraldo M; Pea F; Poz D; Furlanut M
Pharmacol Res; 2001 Jun; 43(6):547-51. PubMed ID: 11419964
[TBL] [Abstract][Full Text] [Related]
7. How to convert from traditional cyclosporine to the microemulsion formulation in stable renal transplant patients?
Gaspari F; Perico N; Pisoni R; Anedda MF; Signorini O; Caruso R; Gotti E; Remuzzi G
Clin Transplant; 1998 Oct; 12(5):379-90. PubMed ID: 9787945
[TBL] [Abstract][Full Text] [Related]
8. Cyclosporin A absorption profiles in pediatric renal transplant recipients predict the risk of acute rejection.
Weber LT; Armstrong VW; Shipkova M; Feneberg R; Wiesel M; Mehls O; Zimmerhackl LB; Oellerich M; Tönshoff B;
Ther Drug Monit; 2004 Aug; 26(4):415-24. PubMed ID: 15257072
[TBL] [Abstract][Full Text] [Related]
9. Cyclosporine microemulsion (Neoral) absorption profiling and sparse-sample predictors during the first 3 months after renal transplantation.
International Neoral Renal Transplantation Study Group.
Am J Transplant; 2002 Feb; 2(2):148-56. PubMed ID: 12099517
[TBL] [Abstract][Full Text] [Related]
10. Abbreviated kinetic profiles in area-under-the-curve monitoring of cyclosporine therapy. Technical note.
Gaspari F; Perico N; Signorini O; Caruso R; Remuzzi G
Kidney Int; 1998 Dec; 54(6):2146-50. PubMed ID: 9853281
[TBL] [Abstract][Full Text] [Related]
11. Comparative pharmacokinetics and renal effects of cyclosporin A and cyclosporin G in renal allograft recipients.
Gruber SA; Gallichio M; Rosano TG; Kaplan SS; Hughes SE; Urbauer DL; Singh TP; Lempert N; Conti DJ; Stein DS; Drusano G
J Clin Pharmacol; 1997 Jul; 37(7):575-86. PubMed ID: 9243350
[TBL] [Abstract][Full Text] [Related]
12. Improving the therapeutic monitoring of cyclosporin A.
Warrens AN; Waters JB; Salama AD; Lechler RI
Clin Transplant; 1999 Apr; 13(2):193-200. PubMed ID: 10202617
[TBL] [Abstract][Full Text] [Related]
13. Maximum a posteriori Bayesian estimation of oral cyclosporin pharmacokinetics in patients with stable renal transplants.
Leger F; Debord J; Le Meur Y; Rousseau A; Büchler M; Lachâtre G; Paintaud G; Marquet P
Clin Pharmacokinet; 2002; 41(1):71-80. PubMed ID: 11825098
[TBL] [Abstract][Full Text] [Related]
14. Single time point measurement by C2 or C3 is highly predictive in cyclosporine area under the curve estimation immediately after lung transplantation.
Hangler HB; Ruttmann E; Geltner C; Bucher B; Nagiller J; Laufer G; Mueller LC
Clin Transplant; 2008; 22(1):35-40. PubMed ID: 18217903
[TBL] [Abstract][Full Text] [Related]
15. Population pharmacokinetic modeling of oral cyclosporin using NONMEM: comparison of absorption pharmacokinetic models and design of a Bayesian estimator.
Rousseau A; Léger F; Le Meur Y; Saint-Marcoux F; Paintaud G; Buchler M; Marquet P
Ther Drug Monit; 2004 Feb; 26(1):23-30. PubMed ID: 14749545
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of the conventional and microemulsion formulations of cyclosporine in pancreas-kidney transplant recipients with gastroparesis.
van der Pijl JW; Srivastava N; Denouël J; Burggraaf J; Schoemaker RC; van der Woude FJ; Cohen AF
Transplantation; 1996 Aug; 62(4):456-62. PubMed ID: 8781610
[TBL] [Abstract][Full Text] [Related]
17. Population pharmacokinetics of ciclosporin in haematopoietic allogeneic stem cell transplantation with emphasis on limited sampling strategy.
Wilhelm AJ; de Graaf P; Veldkamp AI; Janssen JJ; Huijgens PC; Swart EL
Br J Clin Pharmacol; 2012 Apr; 73(4):553-63. PubMed ID: 21988410
[TBL] [Abstract][Full Text] [Related]
18. Cyclosporin. A review of the pharmacokinetic properties, clinical efficacy and tolerability of a microemulsion-based formulation (Neoral).
Noble S; Markham A
Drugs; 1995 Nov; 50(5):924-41. PubMed ID: 8586033
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetic studies of cyclosporin in Thai kidney transplantation patients.
Kungsamrith T; Eiam-Ong S; Avihingsanon Y; Tungsanga K; Chusil S; Ayudhya DP
J Med Assoc Thai; 2000 Nov; 83(11):1307-17. PubMed ID: 11215860
[TBL] [Abstract][Full Text] [Related]
20. Randomized, international study of cyclosporine microemulsion absorption profiling in renal transplantation with basiliximab immunoprophylaxis.
Internation Neoral Renal Transplantation Study Group
Am J Transplant; 2002 Feb; 2(2):157-66. PubMed ID: 12099518
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
